Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Dec;27(6):479-489.
doi: 10.1111/ijpp.12557. Epub 2019 Jul 9.

Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences

Mingming Zhou  1   2 , Jane Desborough  2 , Anne Parkinson  2 , Kirsty Douglas  3 , David McDonald  4 , Katja Boom  5
Affiliations
Comparative Study

Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences

Mingming Zhou et al. Int J Pharm Pract. 2019 Dec.

Abstract

Objectives: Non-medical prescribers, including pharmacists, have been found to achieve comparable clinical outcomes with doctors for certain health conditions. Legislation supporting pharmacist prescribing (PP) has been implemented in the United Kingdom (UK), Canada and New Zealand (NZ); however, to date, Australian pharmacists have not been extended prescribing rights. The purpose of this review was to describe the barriers to PP found in the literature from the UK, Canada, NZ and Australia, and examine the implications of these for the development of PP in Australia.

Methods: We conducted a scoping review, which included peer-reviewed and grey literature, and consultation with stakeholders. Sources - Scopus, PubMed and CINAHL; Google Scholar, OpenGrey and organisational websites from January 2003 to March 2018 in the UK, Canada, NZ and Australia. Inclusion criteria - articles published in English, related to implementation of PP and articulated barriers to PP.

Key findings: Of 863 unique records, 120 were reviewed and 64 articles were eligible for inclusion. Three key themes emerged: (1) Socio-political context, (2) Resourcing issues and (3) Prescriber competence. The most common barriers were inadequate training regarding diagnostic knowledge and skills, inadequate support from authorities and stakeholders, and insufficient funding/reimbursement.

Conclusions: If implementation of PP is to occur, attention needs to be focused on addressing identified barriers to PP implementation, including fostering a favourable socio-political context and prescriber competence. As such, a concerted effort is required to develop clear policy pathways, including targeted training courses, raising stakeholder recognition of PP and identifying specific funding, infrastructure and resourcing needs to ensure the smooth integration of pharmacist prescribers within interprofessional clinical teams.

Keywords: independent prescribing; non-medical prescribing; prescriptions; primary care; secondary care.

PubMed Disclaimer

References

    1. McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy 2016; 9: 143.
    1. Findlay T, Yen L. Inquiry into Chronic Disease Prevention and Management in Primary Health Care. Canberra: Australia National University. http://ruralhealth.org.au/sites/default/files/documents/nrha-policy-docu... (accessed 10 September 2018).
    1. Bhanbhro S et al. Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature. BMC Health Serv Res 2011; 11: 330.
    1. Cooper RJ et al. Nurse and pharmacist supplementary prescribing in the UK-a thematic review of the literature. Health Policy 2008; 85: 277-292.
    1. Gerard K et al. Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment. Value in Health 2012; 15: 699-707.

MeSH terms